Health
‘Significant humoral response’ following two COVID-19 vaccine doses in RMD patients – medwireNews
Most patients with rheumatic and musculoskeletal diseases mount a humoral immune response following receipt of the second dose…
medwireNews: Most patients with rheumatic and musculoskeletal diseases (RMDs) mount a humoral immune response following receipt of the second dose of the PfizerBioNTech (BNT162b2) vaccine against SARS-CoV-2, say researchers.
Yolanda Braun-Moscovici (Rambam…
Continue Reading
-
Noosa News17 hours agoJazz sellout at The J
-
General16 hours agoAnne-Marie Te Whiu on new book of poetry, Mettle, and why she dedicated it to her younger self
-
General18 hours agoHi-tech search for accused cop-killer hits second week
-
General13 hours agoRecord forecast for Australia’s world-class agriculture